Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS ...

It has taken longer than anticipated, but Chicago Bears quarterback Caleb Williams has reached an inflection point.

The Chicago Bears would love nothing more than to start adding some blowouts to their mounting pile of wins. They'll take the ...

Johnson and Johnson stock has reached a significant milestone, achieving an all-time high of 194.5 USD. According to InvestingPro data, this price sits just below the stock’s 52-week high of $194.48, ...

The Delhi High Court on Wednesday refused to grant interim relief to JNTL Consumer Health, the Indian subsidiary of American ...

Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare ...

The Delhi High Court on Wednesday refused to pass any interim orders allowing JNTL Consumer Health, the Indian subsidiary of ...

Johnson & Johnson's latest dividend declaration translates into an annual growth rate of 4.47%. Learn more about JNJ stock here.

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson Controls International has significantly outperformed the broader market over the past year, and analysts remain ...

The Epstein files, a stock trading ban, and government funding await the speaker once his colleagues join him on the Hill.

Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...